Taro Pharmaceutical Industries (TARO) Revenue & Revenue Breakdown
Taro Pharmaceutical Industries Revenue Highlights
Latest Revenue (Y)
$629.18M
Latest Revenue (Q)
$164.94M
Main Geography (Y)
United States
Taro Pharmaceutical Industries Revenue by Period
Taro Pharmaceutical Industries Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-03-31 | $629.18M | 9.81% |
2023-03-31 | $572.95M | 2.07% |
2022-03-31 | $561.35M | 2.25% |
2021-03-31 | $548.97M | -14.86% |
2020-03-31 | $644.77M | -3.75% |
2019-03-31 | $669.89M | 1.21% |
2018-03-31 | $661.91M | -24.73% |
2017-03-31 | $879.39M | -7.51% |
2016-03-31 | $950.75M | 10.18% |
2015-03-31 | $862.94M | 13.65% |
2014-03-31 | $759.28M | 13.16% |
2013-03-31 | $670.95M | 23.55% |
2012-03-31 | $543.08M | 38.35% |
2010-12-31 | $392.54M | 9.76% |
2009-12-31 | $357.64M | 8.69% |
2008-12-31 | $329.04M | 2.97% |
2007-12-31 | $319.55M | 26.67% |
2006-12-31 | $252.27M | -15.27% |
2005-12-31 | $297.74M | 4.79% |
2004-12-31 | $284.13M | -9.93% |
2003-12-31 | $315.46M | 49.10% |
2002-12-31 | $211.58M | 40.93% |
2001-12-31 | $150.13M | 44.64% |
2000-12-31 | $103.80M | 23.88% |
1999-12-31 | $83.78M | 25.61% |
1998-12-31 | $66.70M | 9.34% |
1997-12-31 | $61.00M | 7.96% |
1996-12-31 | $56.50M | 13.91% |
1995-12-31 | $49.60M | 17.81% |
1994-12-31 | $42.10M | 47.72% |
1993-12-31 | $28.50M | - |
Taro Pharmaceutical Industries Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $164.94M | 4.96% |
2023-12-31 | $157.15M | 6.03% |
2023-09-30 | $148.20M | -6.73% |
2023-06-30 | $158.89M | 8.40% |
2023-03-31 | $146.59M | 5.31% |
2022-12-31 | $139.20M | 6.67% |
2022-09-30 | $130.50M | -16.70% |
2022-06-30 | $156.66M | 9.35% |
2022-03-31 | $143.26M | 3.08% |
2021-12-31 | $138.98M | 5.30% |
2021-09-30 | $131.99M | -10.28% |
2021-06-30 | $147.11M | -0.83% |
2021-03-31 | $148.35M | 5.85% |
2020-12-31 | $140.15M | -1.89% |
2020-09-30 | $142.84M | 21.43% |
2020-06-30 | $117.63M | -32.76% |
2020-03-31 | $174.94M | 18.46% |
2019-12-31 | $147.68M | -8.19% |
2019-09-30 | $160.85M | -0.28% |
2019-06-30 | $161.30M | -10.35% |
2019-03-31 | $179.92M | 2.01% |
2018-12-31 | $176.38M | 10.95% |
2018-09-30 | $158.97M | 2.82% |
2018-06-30 | $154.62M | -11.76% |
2018-03-31 | $175.22M | 12.71% |
2017-12-31 | $155.46M | -8.51% |
2017-09-30 | $169.91M | 5.33% |
2017-06-30 | $161.32M | -17.87% |
2017-03-31 | $196.41M | -10.88% |
2016-12-31 | $220.40M | -3.67% |
2016-09-30 | $228.79M | -2.13% |
2016-06-30 | $233.78M | -11.80% |
2016-03-31 | $265.07M | 2.61% |
2015-12-31 | $258.34M | 21.83% |
2015-09-30 | $212.06M | -1.50% |
2015-06-30 | $215.28M | -11.84% |
2015-03-31 | $244.18M | 2.73% |
2014-12-31 | $237.70M | -5.24% |
2014-09-30 | $250.83M | 92.61% |
2014-06-30 | $130.23M | -30.42% |
2014-03-31 | $187.18M | -12.37% |
2013-12-31 | $213.60M | 4.03% |
2013-09-30 | $205.32M | 34.02% |
2013-06-30 | $153.19M | -7.23% |
2013-03-31 | $165.13M | -11.07% |
2012-12-31 | $185.69M | 15.36% |
2012-09-30 | $160.97M | 1.14% |
2012-06-30 | $159.15M | 9.65% |
2012-03-31 | $145.14M | -2.00% |
2011-12-31 | $148.10M | 7.13% |
2011-09-30 | $138.25M | 23.90% |
2011-06-30 | $111.58M | 3.58% |
2011-03-31 | $107.73M | 5.57% |
2010-12-31 | $102.05M | -1.13% |
2010-09-30 | $103.22M | 5.36% |
2010-06-30 | $97.97M | 10.02% |
2010-03-31 | $89.04M | 8.49% |
2009-12-31 | $82.08M | -12.55% |
2009-09-30 | $93.86M | -3.06% |
2009-06-30 | $96.82M | 14.05% |
2009-03-31 | $84.89M | 17.26% |
2008-12-31 | $72.40M | -19.95% |
2008-09-30 | $90.44M | 2.61% |
2008-06-30 | $88.14M | 0.39% |
2007-12-31 | $87.80M | 21.19% |
2005-12-31 | $72.45M | - |
Taro Pharmaceutical Industries Revenue Breakdown
Taro Pharmaceutical Industries Revenue Breakdown by Country
Annual Revenue by Country
Country | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|---|---|---|---|---|
CANADA | $136.24M | $130.07M | - | - | - |
United States | $363.06M | $376.68M | - | - | - |
Other Country | - | $6.69M | $8.40M | $8.28M | $8.76M |
ISRAEL | - | $47.91M | $46.57M | $42.82M | $40.05M |
Canada And Cayman Islands | - | - | $110.17M | $98.00M | $83.97M |
UNITED STATES | - | - | $383.83M | $495.67M | $537.11M |
Latest
Taro Pharmaceutical Industries Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RDY | Dr. Reddy's Laboratories | $279.16B | - |
PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
PAHC | Phibro Animal Health | $977.89M | $273.16M |
EVO | Evotec SE | $781.43M | $208.73M |
PCRX | Pacira BioSciences | $674.98M | $168.57M |
SUPN | Supernus Pharmaceuticals | $607.52M | $175.69M |
AMPH | Amphastar Pharmaceuticals | $593.24M | $188.82M |
COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
ORGO | Organogenesis | $433.14M | $115.18M |
LFCR | Lifecore Biomedical | $128.26M | $24.70M |
RDHL | RedHill Biopharma | $6.51M | $1.80M |